Vertex Pharmaceuticals
Get Full AccessDescription
- Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene and TRIKAFTA for the treatment of patients with CF 12 years of age or older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator, or CFTR, gene. Its pipeline includes Pipeline for Alpha-1 antitrypsin deficiency that is in Phase 2 clinical trial VX-864, a second investigational small molecule corrector for the treatment of AAT deficiency, which is in Phase 1 clinical trial and VX-147 that completed a Phase 1 clinical trial for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. Vertex Pharmaceuticals Incorporated has collaborations with CRISPR Therapeutics AG Arbor Biotechnologies, Inc. Moderna, Inc. Genomics plc Merck KGaA Darmstadt, Germany X-Chem, Inc. Janssen Pharmaceuticals, Inc. Merck KGaA Kymera Therapeutics Ribometrix, Inc. Molecular Templates, Inc. and Affinia Therapeutics, as well as a strategic research collaboration and licensing agreement with Obsidian Therapeutics, Inc. for the discovery of novel therapies that regulate gene editing for the treatment of serious diseases. The company was founded in 1989 and is headquartered in Boston, Massachusetts.
-
Headquarters:50 Northern Avenue , Boston, Massachusetts, United States
More -
Phone Number: +1 617-341-6100
-
-
Employees:3561
-
Revenue:> $1B
-
Legal Name:Vertex Pharmaceuticals
-
Vertex Pharmaceuticals's Social Media
-
Is this data correct?
-
| NAICS Code: 541715 |
NYSE: VRTX
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Vertex Pharmaceuticals
-
Where are Vertex Pharmaceuticals's Headquarters?
Vertex Pharmaceuticals's Headquarters are in 50 Northern Avenue ,Boston,Massachusetts,United States
-
What is Vertex Pharmaceuticals's phone number?
Vertex Pharmaceuticals's phone number is +1 617-341-6100
-
What is Vertex Pharmaceuticals's stock symbol?
Vertex Pharmaceuticals's stock symbol is VRTX
-
What is Vertex Pharmaceuticals's official website?
Vertex Pharmaceuticals's official website is https://www.vrtx.com/about-us/locations/
-
What is Vertex Pharmaceuticals's Revenue?
Vertex Pharmaceuticals's revenue is > $1B
-
What is Vertex Pharmaceuticals's NAICS code?
Vertex Pharmaceuticals's NAICS code is 541715
-
How many employees are working in Vertex Pharmaceuticals
Vertex Pharmaceuticals has 3561 employees
-
What is Vertex Pharmaceuticals's Industry?
Vertex Pharmaceuticals is in the industry of Biotechnology